Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree.

World journal of hepatology

Pecchi A, Besutti G, De Santis M, Del Giovane C, Nosseir S, Tarantino G, Di Benedetto F, Torricelli P.
PMID: 25729483
World J Hepatol. 2015 Feb 27;7(2):276-84. doi: 10.4254/wjh.v7.i2.276.

AIM: To evaluate the relationship between hepatocellular carcinoma (HCC) vascularity and grade; to describe patterns and vascular/histopathological variations of post-transplantation recurrence.METHODS: This retrospective study included 165 patients (143 men, 22 women; median age 56.8 years, range 28-70.4 years) transplanted...

Cite
Pecchi A, Besutti G, De Santis M, et al. Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree. World J Hepatol. 2015;7(2):276-84doi: 10.4254/wjh.v7.i2.276.
Pecchi, A., Besutti, G., De Santis, M., Del Giovane, C., Nosseir, S., Tarantino, G., Di Benedetto, F., & Torricelli, P. (2015). Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree. World journal of hepatology, 7(2), 276-84. https://doi.org/10.4254/wjh.v7.i2.276
Pecchi, Annarita, et al. "Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree." World journal of hepatology vol. 7,2 (2015): 276-84. doi: https://doi.org/10.4254/wjh.v7.i2.276
Pecchi A, Besutti G, De Santis M, Del Giovane C, Nosseir S, Tarantino G, Di Benedetto F, Torricelli P. Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree. World J Hepatol. 2015 Feb 27;7(2):276-84. doi: 10.4254/wjh.v7.i2.276. PMID: 25729483; PMCID: PMC4342610.
Copy Download .nbib Format: NLM
Supplementary Data.

Recenti progressi in medicina

Amato L, Vecchi S, Barbui C, Cruciani F, D'Amico R, Del Giovane C, Minozzi S, Mitrova Z, Saulle R, Davoli M.
PMID: 30394409
Recenti Prog Med. 2018 Oct;109(10):1e-19e. doi: 10.1701/3010.30090.

No abstract available.

Cite
Amato L, Vecchi S, Barbui C, et al. Dati supplementari. Supplementary Data. Recenti Prog Med. 2018;109(10):1e-19edoi: 10.1701/3010.30090.
Amato, L., Vecchi, S., Barbui, C., Cruciani, F., D'Amico, R., Del Giovane, C., Minozzi, S., Mitrova, Z., Saulle, R., & Davoli, M. (2018). Dati supplementari. Supplementary Data. Recenti progressi in medicina, 109(10), 1e-19e. https://doi.org/10.1701/3010.30090
Amato, Laura, et al. "Dati supplementari." Supplementary Data. Recenti progressi in medicina vol. 109,10 (2018): 1e-19e. doi: https://doi.org/10.1701/3010.30090
Amato L, Vecchi S, Barbui C, Cruciani F, D'Amico R, Del Giovane C, Minozzi S, Mitrova Z, Saulle R, Davoli M. Dati supplementari. Supplementary Data. Recenti Prog Med. 2018 Oct;109(10):1e-19e. doi: 10.1701/3010.30090. Italian. PMID: 30394409.
Copy Download .nbib Format: NLM
Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youths: The Best Evidence Synthesis Is a Strong Call for Further Evidence.

Journal of the American Academy of Child and Adolescent Psychiatry

Cortese S, Frazier JA, Del Giovane C.
PMID: 34273494
J Am Acad Child Adolesc Psychiatry. 2021 Jul 14; doi: 10.1016/j.jaac.2021.07.004. Epub 2021 Jul 14.

Before the network meta-analysis (NMA) by DelBello et al. in this issue of the Journal, no NMA had been published on the pharmacological treatment of bipolar depression in youths. DelBello et al. have filled this gap by conducting the...

Cite
Cortese S, Frazier JA, Del Giovane C. Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youths: The Best Evidence Synthesis Is a Strong Call for Further Evidence. J Am Acad Child Adolesc Psychiatry. 2021;doi: 10.1016/j.jaac.2021.07.004.
Cortese, S., Frazier, J. A., & Del Giovane, C. (2021). Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youths: The Best Evidence Synthesis Is a Strong Call for Further Evidence. Journal of the American Academy of Child and Adolescent Psychiatry, . https://doi.org/10.1016/j.jaac.2021.07.004
Cortese, Samuele, et al. "Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youths: The Best Evidence Synthesis Is a Strong Call for Further Evidence." Journal of the American Academy of Child and Adolescent Psychiatry vol. (2021). doi: https://doi.org/10.1016/j.jaac.2021.07.004
Cortese S, Frazier JA, Del Giovane C. Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youths: The Best Evidence Synthesis Is a Strong Call for Further Evidence. J Am Acad Child Adolesc Psychiatry. 2021 Jul 14; doi: 10.1016/j.jaac.2021.07.004. Epub 2021 Jul 14. PMID: 34273494.
Copy Download .nbib Format: NLM
Rituximab for people with multiple sclerosis.

The Cochrane database of systematic reviews

Filippini G, Kruja J, Del Giovane C.
PMID: 34748215
Cochrane Database Syst Rev. 2021 Nov 08;11:CD013874. doi: 10.1002/14651858.CD013874.pub2.

BACKGROUND: Multiple sclerosis (MS) is the most common neurological cause of disability in young adults. Off-label rituximab for MS is used in most countries surveyed by the International Federation of MS, including high-income countries where on-label disease-modifying treatments (DMTs)...

Cite
Filippini G, Kruja J, Del Giovane C. Rituximab for people with multiple sclerosis. Cochrane Database Syst Rev. 2021;11:CD013874doi: 10.1002/14651858.CD013874.pub2.
Filippini, G., Kruja, J., & Del Giovane, C. (2021). Rituximab for people with multiple sclerosis. The Cochrane database of systematic reviews, 11CD013874. https://doi.org/10.1002/14651858.CD013874.pub2
Filippini, Graziella, et al. "Rituximab for people with multiple sclerosis." The Cochrane database of systematic reviews vol. 11 (2021): CD013874. doi: https://doi.org/10.1002/14651858.CD013874.pub2
Filippini G, Kruja J, Del Giovane C. Rituximab for people with multiple sclerosis. Cochrane Database Syst Rev. 2021 Nov 08;11:CD013874. doi: 10.1002/14651858.CD013874.pub2. PMID: 34748215; PMCID: PMC8574640.
Copy Download .nbib Format: NLM
Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.

Stroke

Boncoraglio GB, Del Giovane C, Tramacere I.
PMID: 33902303
Stroke. 2021 Jun;52(6):1974-1982. doi: 10.1161/STROKEAHA.120.031945. Epub 2021 Apr 27.

BACKGROUND AND PURPOSE: Approximately 30% of ischemic strokes occur after a previous stroke or transient ischemic attack. Arterial hypertension is one of the best established risk factors for first and recurrent stroke, both ischemic and hemorrhagic. Guidelines for the...

Cite
Boncoraglio GB, Del Giovane C, Tramacere I. Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Stroke. 2021;52(6):1974-1982doi: 10.1161/STROKEAHA.120.031945.
Boncoraglio, G. B., Del Giovane, C., & Tramacere, I. (2021). Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Stroke, 52(6), 1974-1982. https://doi.org/10.1161/STROKEAHA.120.031945
Boncoraglio, Giorgio B, et al. "Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis." Stroke vol. 52,6 (2021): 1974-1982. doi: https://doi.org/10.1161/STROKEAHA.120.031945
Boncoraglio GB, Del Giovane C, Tramacere I. Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Stroke. 2021 Jun;52(6):1974-1982. doi: 10.1161/STROKEAHA.120.031945. Epub 2021 Apr 27. PMID: 33902303.
Copy Download .nbib Format: NLM
Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.

PloS one

Papazoglou DD, Baretella O, Feller M, Del Giovane C, Moutzouri E, Aujesky D, Schwenkglenks M, O'Mahony D, Knol W, Dalleur O, Rodondi N, Baumgartner C.
PMID: 34784405
PLoS One. 2021 Nov 16;16(11):e0260112. doi: 10.1371/journal.pone.0260112. eCollection 2021.

BACKGROUND: Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study...

Cite
Papazoglou DD, Baretella O, Feller M, et al. Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients. PLoS One. 2021;16(11):e0260112doi: 10.1371/journal.pone.0260112.
Papazoglou, D. D., Baretella, O., Feller, M., Del Giovane, C., Moutzouri, E., Aujesky, D., Schwenkglenks, M., O'Mahony, D., Knol, W., Dalleur, O., Rodondi, N., & Baumgartner, C. (2021). Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients. PloS one, 16(11), e0260112. https://doi.org/10.1371/journal.pone.0260112
Papazoglou, Dimitrios David, et al. "Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients." PloS one vol. 16,11 (2021): e0260112. doi: https://doi.org/10.1371/journal.pone.0260112
Papazoglou DD, Baretella O, Feller M, Del Giovane C, Moutzouri E, Aujesky D, Schwenkglenks M, O'Mahony D, Knol W, Dalleur O, Rodondi N, Baumgartner C. Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients. PLoS One. 2021 Nov 16;16(11):e0260112. doi: 10.1371/journal.pone.0260112. eCollection 2021. PMID: 34784405; PMCID: PMC8594840.
Copy Download .nbib Format: NLM
Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.

Stroke

Boncoraglio GB, Del Giovane C, Tramacere I.
PMID: 33902303
Stroke. 2021 Jun;52(6):1974-1982. doi: 10.1161/STROKEAHA.120.031945. Epub 2021 Apr 27.

BACKGROUND AND PURPOSE: Approximately 30% of ischemic strokes occur after a previous stroke or transient ischemic attack. Arterial hypertension is one of the best established risk factors for first and recurrent stroke, both ischemic and hemorrhagic. Guidelines for the...

Cite
Boncoraglio GB, Del Giovane C, Tramacere I. Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Stroke. 2021;52(6):1974-1982doi: 10.1161/STROKEAHA.120.031945.
Boncoraglio, G. B., Del Giovane, C., & Tramacere, I. (2021). Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Stroke, 52(6), 1974-1982. https://doi.org/10.1161/STROKEAHA.120.031945
Boncoraglio, Giorgio B, et al. "Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis." Stroke vol. 52,6 (2021): 1974-1982. doi: https://doi.org/10.1161/STROKEAHA.120.031945
Boncoraglio GB, Del Giovane C, Tramacere I. Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis. Stroke. 2021 Jun;52(6):1974-1982. doi: 10.1161/STROKEAHA.120.031945. Epub 2021 Apr 27. PMID: 33902303.
Copy Download .nbib Format: NLM
Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis.

World psychiatry : official journal of the World Psychiatric Association (WPA)

Zhou X, Hetrick SE, Cuijpers P, Qin B, Barth J, Whittington CJ, Cohen D, Del Giovane C, Liu Y, Michael KD, Zhang Y, Weisz JR, Xie P.
PMID: 26043339
World Psychiatry. 2015 Jun;14(2):207-22. doi: 10.1002/wps.20217.

Previous meta-analyses of psychotherapies for child and adolescent depression were limited because of the small number of trials with direct comparisons between two treatments. A network meta-analysis, a novel approach that integrates direct and indirect evidence from randomized controlled...

Cite
Zhou X, Hetrick SE, Cuijpers P, et al. Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis. World Psychiatry. 2015;14(2):207-22doi: 10.1002/wps.20217.
Zhou, X., Hetrick, S. E., Cuijpers, P., Qin, B., Barth, J., Whittington, C. J., Cohen, D., Del Giovane, C., Liu, Y., Michael, K. D., Zhang, Y., Weisz, J. R., & Xie, P. (2015). Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis. World psychiatry : official journal of the World Psychiatric Association (WPA), 14(2), 207-22. https://doi.org/10.1002/wps.20217
Zhou, Xinyu, et al. "Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis." World psychiatry : official journal of the World Psychiatric Association (WPA) vol. 14,2 (2015): 207-22. doi: https://doi.org/10.1002/wps.20217
Zhou X, Hetrick SE, Cuijpers P, Qin B, Barth J, Whittington CJ, Cohen D, Del Giovane C, Liu Y, Michael KD, Zhang Y, Weisz JR, Xie P. Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis. World Psychiatry. 2015 Jun;14(2):207-22. doi: 10.1002/wps.20217. PMID: 26043339; PMCID: PMC4471978.
Copy Download .nbib Format: NLM
Evaluating the Quality of Evidence from a Network Meta-Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Higgins JP, Del Giovane C, Chaimani A, Caldwell DM, Salanti G.
PMID: 27200533
Value Health. 2014 Nov;17(7):A324. doi: 10.1016/j.jval.2014.08.572. Epub 2014 Oct 26.

No abstract available.

Cite
Higgins JP, Del Giovane C, Chaimani A, et al. Evaluating the Quality of Evidence from a Network Meta-Analysis. Value Health. 2014;17(7):A324doi: 10.1016/j.jval.2014.08.572.
Higgins, J. P., Del Giovane, C., Chaimani, A., Caldwell, D. M., & Salanti, G. (2014). Evaluating the Quality of Evidence from a Network Meta-Analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A324. https://doi.org/10.1016/j.jval.2014.08.572
Higgins, J P, et al. "Evaluating the Quality of Evidence from a Network Meta-Analysis." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A324. doi: https://doi.org/10.1016/j.jval.2014.08.572
Higgins JP, Del Giovane C, Chaimani A, Caldwell DM, Salanti G. Evaluating the Quality of Evidence from a Network Meta-Analysis. Value Health. 2014 Nov;17(7):A324. doi: 10.1016/j.jval.2014.08.572. Epub 2014 Oct 26. PMID: 27200533.
Copy Download .nbib Format: NLM
Prevalence and factors associated with chronic use of levothyroxine: A cohort study.

PloS one

Janett-Pellegri C, Wildisen L, Feller M, Del Giovane C, Moutzouri E, Grolimund O, Walter P, Waeber G, Marques-Vidal P, Vollenweider P, Rodondi N.
PMID: 34928965
PLoS One. 2021 Dec 20;16(12):e0261160. doi: 10.1371/journal.pone.0261160. eCollection 2021.

IMPORTANCE: Levothyroxine prescriptions are rising worldwide. However, there are few data on factors associated with chronic use.OBJECTIVE: To assess the prevalence of chronic levothyroxine use, its rank among other chronic drugs and factors associated with chronic use. To assess...

Cite
Janett-Pellegri C, Wildisen L, Feller M, et al. Prevalence and factors associated with chronic use of levothyroxine: A cohort study. PLoS One. 2021;16(12):e0261160doi: 10.1371/journal.pone.0261160.
Janett-Pellegri, C., Wildisen, L., Feller, M., Del Giovane, C., Moutzouri, E., Grolimund, O., Walter, P., Waeber, G., Marques-Vidal, P., Vollenweider, P., & Rodondi, N. (2021). Prevalence and factors associated with chronic use of levothyroxine: A cohort study. PloS one, 16(12), e0261160. https://doi.org/10.1371/journal.pone.0261160
Janett-Pellegri, Camilla, et al. "Prevalence and factors associated with chronic use of levothyroxine: A cohort study." PloS one vol. 16,12 (2021): e0261160. doi: https://doi.org/10.1371/journal.pone.0261160
Janett-Pellegri C, Wildisen L, Feller M, Del Giovane C, Moutzouri E, Grolimund O, Walter P, Waeber G, Marques-Vidal P, Vollenweider P, Rodondi N. Prevalence and factors associated with chronic use of levothyroxine: A cohort study. PLoS One. 2021 Dec 20;16(12):e0261160. doi: 10.1371/journal.pone.0261160. eCollection 2021. PMID: 34928965.
Copy Download .nbib Format: NLM
Prevalence and factors associated with chronic use of levothyroxine: A cohort study.

PloS one

Janett-Pellegri C, Wildisen L, Feller M, Del Giovane C, Moutzouri E, Grolimund O, Walter P, Waeber G, Marques-Vidal P, Vollenweider P, Rodondi N.
PMID: 34928965
PLoS One. 2021 Dec 20;16(12):e0261160. doi: 10.1371/journal.pone.0261160. eCollection 2021.

IMPORTANCE: Levothyroxine prescriptions are rising worldwide. However, there are few data on factors associated with chronic use.OBJECTIVE: To assess the prevalence of chronic levothyroxine use, its rank among other chronic drugs and factors associated with chronic use. To assess...

Cite
Janett-Pellegri C, Wildisen L, Feller M, et al. Prevalence and factors associated with chronic use of levothyroxine: A cohort study. PLoS One. 2021;16(12):e0261160doi: 10.1371/journal.pone.0261160.
Janett-Pellegri, C., Wildisen, L., Feller, M., Del Giovane, C., Moutzouri, E., Grolimund, O., Walter, P., Waeber, G., Marques-Vidal, P., Vollenweider, P., & Rodondi, N. (2021). Prevalence and factors associated with chronic use of levothyroxine: A cohort study. PloS one, 16(12), e0261160. https://doi.org/10.1371/journal.pone.0261160
Janett-Pellegri, Camilla, et al. "Prevalence and factors associated with chronic use of levothyroxine: A cohort study." PloS one vol. 16,12 (2021): e0261160. doi: https://doi.org/10.1371/journal.pone.0261160
Janett-Pellegri C, Wildisen L, Feller M, Del Giovane C, Moutzouri E, Grolimund O, Walter P, Waeber G, Marques-Vidal P, Vollenweider P, Rodondi N. Prevalence and factors associated with chronic use of levothyroxine: A cohort study. PLoS One. 2021 Dec 20;16(12):e0261160. doi: 10.1371/journal.pone.0261160. eCollection 2021. PMID: 34928965; PMCID: PMC8687586.
Copy Download .nbib Format: NLM
Association between colorectal cancer testing and insurance type: Evidence from the Swiss Health Interview Survey 2012.

Preventive medicine reports

Braun AL, Kässner A, Syrogiannouli L, Selby K, Bulliard JL, Martin Y, Guessous I, Tal K, Del Giovane C, Zwahlen M, Auer R.
PMID: 32426215
Prev Med Rep. 2020 May 04;19:101111. doi: 10.1016/j.pmedr.2020.101111. eCollection 2020 Sep.

Both colonoscopy and fecal occult blood test (FOBT) are commonly used for colorectal cancer (CRC) screening, but colonoscopy costs much more than FOBT. Swiss insurance offers high or low deductibles and choice of basic or private insurance. We hypothesized...

Cite
Braun AL, Kässner A, Syrogiannouli L, et al. Association between colorectal cancer testing and insurance type: Evidence from the Swiss Health Interview Survey 2012. Prev Med Rep. 2020;19:101111doi: 10.1016/j.pmedr.2020.101111.
Braun, A. L., Kässner, A., Syrogiannouli, L., Selby, K., Bulliard, J. L., Martin, Y., Guessous, I., Tal, K., Del Giovane, C., Zwahlen, M., & Auer, R. (2020). Association between colorectal cancer testing and insurance type: Evidence from the Swiss Health Interview Survey 2012. Preventive medicine reports, 19101111. https://doi.org/10.1016/j.pmedr.2020.101111
Braun, Alexander Leonhard, et al. "Association between colorectal cancer testing and insurance type: Evidence from the Swiss Health Interview Survey 2012." Preventive medicine reports vol. 19 (2020): 101111. doi: https://doi.org/10.1016/j.pmedr.2020.101111
Braun AL, Kässner A, Syrogiannouli L, Selby K, Bulliard JL, Martin Y, Guessous I, Tal K, Del Giovane C, Zwahlen M, Auer R. Association between colorectal cancer testing and insurance type: Evidence from the Swiss Health Interview Survey 2012. Prev Med Rep. 2020 May 04;19:101111. doi: 10.1016/j.pmedr.2020.101111. eCollection 2020 Sep. PMID: 32426215; PMCID: PMC7226870.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries